JanOne is a biotechnology company focused on developing treatments for diseases that cause severe pain, aiming to offer non-addictive pain relief solutions. The company's primary focus is on Peripheral Artery Disease (PAD), seeking to advance its treatment through clinical trials and reduce opioid prescriptions.